DNase, 리가제, RNA 폴리메라제 시장 : 규모, 점유율, 동향 분석 보고서 - DNase 용도별, 리가제 용도별, RNA 폴리메라제 용도별, 지역별 전망 및 예측(2024-2031년)

The Global DNases, Ligases, And RNA Polymerases Market size is expected to reach $1.6 billion by 2031, rising at a market growth of 10.4% CAGR during the forecast period.

North America is home to some of the world's leading biotechnology and pharmaceutical companies, particularly the United States. Thus, the North America region acquired $273.68 million revenue in 2023. Increased use of DNases, Ligases, And RNA Polymerases results from this financial support. These enzymes are necessary for various molecular biology and genetic engineering applications. Specific grants and subsidies targeted at innovative pharmaceutical research bolster the demand for these enzymes as they are critical tools in developing new drugs and therapies.

The major strategies followed by the market participants are Partnerships as the key developmental strategy to keep pace with the changing demands of end users. For instance, In 2022, February, QIAGEN formed a partnership with Singular Genomics Systems to verify its QIAseq kits, a product line for both RNA and DNA sample prep, with the G4 analysis platform. Additionally, In 2021, August, QIAGEN came into a partnership with GT Molecular to deliver a comprehensive wastewater workflow solution developed to allow management of COVID-19 outbreaks by U.S. and Canadian laboratories, with forthcoming opportunities to deliver the solution in other countries.

Based on the Analysis presented in the KBV Cardinal matrix; Thermo Fisher Scientific, Inc. is the forerunner in the DNases, Ligases, And RNA Polymerases Market. In February 2022, Thermo Fisher Scientific joined hands with Moderna, a biotechnology company developing messenger RNA. Under this collaboration, the companies aimed to allow reliable large-scale manufacturing in the U.S. of Spikevax, Moderna's COVID-19 vaccine, and other investigational mRNA drugs in its channel. Companies such as Merck KGaA, Agilent Technologies, Inc., Qiagen N.V are some of the key innovators in DNases, Ligases, And RNA Polymerases Market.

COVID-19 Impact Analysis

In the early stages of the pandemic, disruptions to global supply chains, logistics, and manufacturing operations affected the availability of DNases, Ligases, RNA Polymerases, and other molecular biology reagents. Border closures, travel restrictions, and lockdown measures impeded the movement of goods, leading to product shipment and distribution delays. The COVID-19 pandemic disrupted research and development activities in academic institutions, biotechnology companies, and pharmaceutical firms, affecting experimental timelines and project progress. Thus, the Impact of the COVID-19 pandemic had a moderate impact on the market.

Market Growth Factors

Genomic research involves the study of DNA and RNA sequences to understand genetic variations, gene expression patterns, and molecular mechanisms underlying biological processes. DNases, Ligases, And RNA Polymerases are essential enzymes used in nucleic acid manipulation techniques such as sequencing, PCR amplification, cloning, and gene expression analysis, driving market demand. Hence, the expansion of genomic research is driving the market's growth.

The biotechnology and pharmaceutical industries rely heavily on DNases, Ligases, And RNA Polymerases for various applications in biopharmaceutical development. These enzymes are essential for molecular cloning, gene expression, protein production, and recombinant DNA technology used in biologics production, such as therapeutic proteins, monoclonal antibodies, and gene therapies. Thus, the biotechnology and pharmaceutical industries are propelling the market's growth.

Market Restraining Factors

Enzyme production involves complex manufacturing processes, including fermentation, purification, and formulation, which require specialized equipment, facilities, and expertise. These processes are resource-intensive and require substantial investments in infrastructure, technology, and skilled personnel, contributing to high production costs. Therefore, the high enzyme production costs are propelling the market's growth.

DNases Application Outlook

Based on DNases application, the market is divided into biopharmaceutical processing and others. The others segment witnessed a 23% revenue share in the market in 2023. DNases are utilized in environmental biotechnology to degrade DNA contaminants in soil and water, aiding in the bioremediation of polluted environments. DNases are also used in the food industry to remove DNA from food products, such as dairy and meat, to prevent spoilage and improve shelf life.

Ligases Application Outlook

On the basis of Ligases application, the market is segmented into oligonucleotide synthesis and other. In 2023, the other segments attained a 56% revenue share in the market. Ligases join DNA fragments, such as vectors, during molecular cloning and subcloning procedures and insert DNA. They facilitate the assembly of synthetic genes by ligating oligonucleotide fragments into longer DNA sequences.

RNA Polymerases Application Outlook

By RNA polymerases application, the market is divided into mRNA production and others. The others segment procured a remarkable revenue share in the market in 2023. RNA polymerases are utilized in IVT reactions to produce RNA transcripts from DNA templates in vitro. These synthetic RNA molecules serve as valuable tools in molecular biology research, enabling the generation of RNA probes, standards, controls, and expression vectors for various applications.

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2023, the Asia Pacific region generated a substantial 28% revenue share in the market. The Asia Pacific region is home to large-scale genomic research initiatives to understand genetic variations, disease mechanisms, and population genetics. DNases, Ligases, And RNA Polymerases play crucial roles in genomic research, including DNA sequencing, gene expression analysis, and genome editing, driving demand for enzyme products in academic and research institutions across the region.

Recent Strategies Deployed in the Market

• Jan-2023: Agilent Technologies Inc. took over Avida Biomed, an early-stage life sciences company developing high-performance target enrichment workflows with unique capabilities. This acquisition would complement company's market-leading SureSelect portfolio and further augment Agilent's strategy to expand into the high-growth clinical research and diagnostics markets.
• Feb-2022: Thermo Fisher Scientific joined hands with Moderna, a biotechnology company developing messenger RNA. Under this collaboration, the companies aimed to allow reliable large-scale manufacturing in the U.S. of Spikevax, Moderna's COVID-19 vaccine, and other investigational mRNA drugs in its channel.
• Feb-2022: Merck KGaA came into a partnership with eTheRNA, a science and technology organization. Together the companies would target messenger RNA therapeutics using eTheRNA's mRNA and lipid nanoparticle technologies in multiple model methods. Additionally, mRNA encoding antigens would be selected by Merck KGaA as suitable for human diseases. Moreover, eTheRNA acquires immunotherapies that target the essential role of dendritic cells in the human immune system.
• Feb-2022: Merck completed the acquisition of Exelead, a biopharmaceutical contract development, and manufacturing business. Through this acquisition, Exelead's leading abilities, and highly experienced crew, Merck acquires a crucial landmark in evolving one of the supreme CDMO players in mRNA vaccines and therapeutics, delivering a combined CDMO across the mRNA value chain from pre-clinical to retail.
• Feb-2022: QIAGEN formed a partnership with Singular Genomics Systems, a company leveraging novel next-generation sequencing. With this partnership, QIAGEN aimed to verify its QIAseq kits, a product line for both RNA and DNA sample prep, with the G4 analysis platform. Additionally, this partnership would highlight QIAGEN's dedication to delivering a plug-and-play solution for consumers to combine the G4 into living NGS workflows.

List of Key Companies Profiled

• Thermo Fisher Scientific, Inc.
• Merck KGaA
• Agilent Technologies, Inc.
• Promega Corporation
• Raybiotech Life, Inc.
• Qiagen N.V
• Abnova Corporation
• Takara Bio Inc. (Takara Holdings Inc.)
• BPS Bioscience, Inc.
• New England Biolabs, Inc.

Global DNases, Ligases, And RNA Polymerases Market Report Segmentation

By DNases Application

• Biopharmaceutical Processing
• Others

By Ligases Application

• Oligonucleotide Synthesis
• Others

By RNA Polymerases Application

• mRNA Production
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology

• 1.1 Market Definition
• 1.2 Objectives
• 1.3 Market Scope
• 1.4 Segmentation
  • 1.4.1 Global DNases, Ligases, And RNA Polymerases Market, by DNases Application
  • 1.4.2 Global DNases, Ligases, And RNA Polymerases Market, by Ligases Application
  • 1.4.3 Global DNases, Ligases, And RNA Polymerases Market, by RNA Polymerases Application
  • 1.4.4 Global DNases, Ligases, And RNA Polymerases Market, by Geography
• 1.5 Methodology for the research

Chapter 2. Market at a Glance

• 2.1 Key Highlights

Chapter 3. Market Overview

• 3.1 Introduction
  • 3.1.1 Overview
    • 3.1.1.1 Market Composition and Scenario
• 3.2 Key Factors Impacting the Market
  • 3.2.1 Market Drivers
  • 3.2.2 Market Restraints
  • 3.2.3 Market Opportunities
  • 3.2.4 Market Challenges

Chapter 4. Competition Analysis - Global

• 4.1 KBV Cardinal Matrix
• 4.2 Recent Industry Wide Strategic Developments
  • 4.2.1 Partnerships, Collaborations and Agreements
  • 4.2.2 Product Launches and Product Expansions
  • 4.2.3 Acquisition and Mergers
  • 4.2.4 Geographical Expansions
• 4.3 Top Winning Strategies
  • 4.3.1 Key Leading Strategies: Percentage Distribution (2020-2024)
• 4.4 Porter Five Forces Analysis

Chapter 5. Global DNases, Ligases, And RNA Polymerases Market by DNases Application

• 5.1 Global Biopharmaceutical Processing Market by Region
• 5.2 Global Others Market by Region

Chapter 6. Global DNases, Ligases, And RNA Polymerases Market by Ligases Application

• 6.1 Global Oligonucleotide Synthesis Market by Region
• 6.2 Global Others Market by Region

Chapter 7. Global DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application

• 7.1 Global mRNA Production Market by Region
• 7.2 Global Others Market by Region

Chapter 8. Global DNases, Ligases, And RNA Polymerases Market by Region

• 8.1 North America DNases, Ligases, And RNA Polymerases Market
  • 8.1.1 North America DNases, Ligases, And RNA Polymerases Market by DNases Application
    • 8.1.1.1 North America Biopharmaceutical Processing Market by Region
    • 8.1.1.2 North America Others Market by Region
  • 8.1.2 North America DNases, Ligases, And RNA Polymerases Market by Ligases Application
    • 8.1.2.1 North America Oligonucleotide Synthesis Market by Country
    • 8.1.2.2 North America Others Market by Country
  • 8.1.3 North America DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
    • 8.1.3.1 North America mRNA Production Market by Country
    • 8.1.3.2 North America Others Market by Country
  • 8.1.4 North America DNases, Ligases, And RNA Polymerases Market by Country
    • 8.1.4.1 US DNases, Ligases, And RNA Polymerases Market
      • 8.1.4.1.1 US DNases, Ligases, And RNA Polymerases Market by DNases Application
      • 8.1.4.1.2 US DNases, Ligases, And RNA Polymerases Market by Ligases Application
      • 8.1.4.1.3 US DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
    • 8.1.4.2 Canada DNases, Ligases, And RNA Polymerases Market
      • 8.1.4.2.1 Canada DNases, Ligases, And RNA Polymerases Market by DNases Application
      • 8.1.4.2.2 Canada DNases, Ligases, And RNA Polymerases Market by Ligases Application
      • 8.1.4.2.3 Canada DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
    • 8.1.4.3 Mexico DNases, Ligases, And RNA Polymerases Market
      • 8.1.4.3.1 Mexico DNases, Ligases, And RNA Polymerases Market by DNases Application
      • 8.1.4.3.2 Mexico DNases, Ligases, And RNA Polymerases Market by Ligases Application
      • 8.1.4.3.3 Mexico DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
    • 8.1.4.4 Rest of North America DNases, Ligases, And RNA Polymerases Market
      • 8.1.4.4.1 Rest of North America DNases, Ligases, And RNA Polymerases Market by DNases Application
      • 8.1.4.4.2 Rest of North America DNases, Ligases, And RNA Polymerases Market by Ligases Application
      • 8.1.4.4.3 Rest of North America DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
• 8.2 Europe DNases, Ligases, And RNA Polymerases Market
  • 8.2.1 Europe DNases, Ligases, And RNA Polymerases Market by DNases Application
    • 8.2.1.1 Europe Biopharmaceutical Processing Market by Country
    • 8.2.1.2 Europe Others Market by Country
  • 8.2.2 Europe DNases, Ligases, And RNA Polymerases Market by Ligases Application
    • 8.2.2.1 Europe Oligonucleotide Synthesis Market by Country
    • 8.2.2.2 Europe Others Market by Country
  • 8.2.3 Europe DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
    • 8.2.3.1 Europe mRNA Production Market by Country
    • 8.2.3.2 Europe Others Market by Country
  • 8.2.4 Europe DNases, Ligases, And RNA Polymerases Market by Country
    • 8.2.4.1 Germany DNases, Ligases, And RNA Polymerases Market
      • 8.2.4.1.1 Germany DNases, Ligases, And RNA Polymerases Market by DNases Application
      • 8.2.4.1.2 Germany DNases, Ligases, And RNA Polymerases Market by Ligases Application
      • 8.2.4.1.3 Germany DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
    • 8.2.4.2 UK DNases, Ligases, And RNA Polymerases Market
      • 8.2.4.2.1 UK DNases, Ligases, And RNA Polymerases Market by DNases Application
      • 8.2.4.2.2 UK DNases, Ligases, And RNA Polymerases Market by Ligases Application
      • 8.2.4.2.3 UK DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
    • 8.2.4.3 France DNases, Ligases, And RNA Polymerases Market
      • 8.2.4.3.1 France DNases, Ligases, And RNA Polymerases Market by DNases Application
      • 8.2.4.3.2 France DNases, Ligases, And RNA Polymerases Market by Ligases Application
      • 8.2.4.3.3 France DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
    • 8.2.4.4 Russia DNases, Ligases, And RNA Polymerases Market
      • 8.2.4.4.1 Russia DNases, Ligases, And RNA Polymerases Market by DNases Application
      • 8.2.4.4.2 Russia DNases, Ligases, And RNA Polymerases Market by Ligases Application
      • 8.2.4.4.3 Russia DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
    • 8.2.4.5 Spain DNases, Ligases, And RNA Polymerases Market
      • 8.2.4.5.1 Spain DNases, Ligases, And RNA Polymerases Market by DNases Application
      • 8.2.4.5.2 Spain DNases, Ligases, And RNA Polymerases Market by Ligases Application
      • 8.2.4.5.3 Spain DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
    • 8.2.4.6 Italy DNases, Ligases, And RNA Polymerases Market
      • 8.2.4.6.1 Italy DNases, Ligases, And RNA Polymerases Market by DNases Application
      • 8.2.4.6.2 Italy DNases, Ligases, And RNA Polymerases Market by Ligases Application
      • 8.2.4.6.3 Italy DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
    • 8.2.4.7 Rest of Europe DNases, Ligases, And RNA Polymerases Market
      • 8.2.4.7.1 Rest of Europe DNases, Ligases, And RNA Polymerases Market by DNases Application
      • 8.2.4.7.2 Rest of Europe DNases, Ligases, And RNA Polymerases Market by Ligases Application
      • 8.2.4.7.3 Rest of Europe DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
• 8.3 Asia Pacific DNases, Ligases, And RNA Polymerases Market
  • 8.3.1 Asia Pacific DNases, Ligases, And RNA Polymerases Market by DNases Application
    • 8.3.1.1 Asia Pacific Biopharmaceutical Processing Market by Country
    • 8.3.1.2 Asia Pacific Others Market by Country
  • 8.3.2 Asia Pacific DNases, Ligases, And RNA Polymerases Market by Ligases Application
    • 8.3.2.1 Asia Pacific Oligonucleotide Synthesis Market by Country
    • 8.3.2.2 Asia Pacific Others Market by Country
  • 8.3.3 Asia Pacific DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
    • 8.3.3.1 Asia Pacific mRNA Production Market by Country
    • 8.3.3.2 Asia Pacific Others Market by Country
  • 8.3.4 Asia Pacific DNases, Ligases, And RNA Polymerases Market by Country
    • 8.3.4.1 China DNases, Ligases, And RNA Polymerases Market
      • 8.3.4.1.1 China DNases, Ligases, And RNA Polymerases Market by DNases Application
      • 8.3.4.1.2 China DNases, Ligases, And RNA Polymerases Market by Ligases Application
      • 8.3.4.1.3 China DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
    • 8.3.4.2 Japan DNases, Ligases, And RNA Polymerases Market
      • 8.3.4.2.1 Japan DNases, Ligases, And RNA Polymerases Market by DNases Application
      • 8.3.4.2.2 Japan DNases, Ligases, And RNA Polymerases Market by Ligases Application
      • 8.3.4.2.3 Japan DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
    • 8.3.4.3 India DNases, Ligases, And RNA Polymerases Market
      • 8.3.4.3.1 India DNases, Ligases, And RNA Polymerases Market by DNases Application
      • 8.3.4.3.2 India DNases, Ligases, And RNA Polymerases Market by Ligases Application
      • 8.3.4.3.3 India DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
    • 8.3.4.4 South Korea DNases, Ligases, And RNA Polymerases Market
      • 8.3.4.4.1 South Korea DNases, Ligases, And RNA Polymerases Market by DNases Application
      • 8.3.4.4.2 South Korea DNases, Ligases, And RNA Polymerases Market by Ligases Application
      • 8.3.4.4.3 South Korea DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
    • 8.3.4.5 Singapore DNases, Ligases, And RNA Polymerases Market
      • 8.3.4.5.1 Singapore DNases, Ligases, And RNA Polymerases Market by DNases Application
      • 8.3.4.5.2 Singapore DNases, Ligases, And RNA Polymerases Market by Ligases Application
      • 8.3.4.5.3 Singapore DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
    • 8.3.4.6 Malaysia DNases, Ligases, And RNA Polymerases Market
      • 8.3.4.6.1 Malaysia DNases, Ligases, And RNA Polymerases Market by DNases Application
      • 8.3.4.6.2 Malaysia DNases, Ligases, And RNA Polymerases Market by Ligases Application
      • 8.3.4.6.3 Malaysia DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
    • 8.3.4.7 Rest of Asia Pacific DNases, Ligases, And RNA Polymerases Market
      • 8.3.4.7.1 Rest of Asia Pacific DNases, Ligases, And RNA Polymerases Market by DNases Application
      • 8.3.4.7.2 Rest of Asia Pacific DNases, Ligases, And RNA Polymerases Market by Ligases Application
      • 8.3.4.7.3 Rest of Asia Pacific DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
• 8.4 LAMEA DNases, Ligases, And RNA Polymerases Market
  • 8.4.1 LAMEA DNases, Ligases, And RNA Polymerases Market by DNases Application
    • 8.4.1.1 LAMEA Biopharmaceutical Processing Market by Country
    • 8.4.1.2 LAMEA Others Market by Country
  • 8.4.2 LAMEA DNases, Ligases, And RNA Polymerases Market by Ligases Application
    • 8.4.2.1 LAMEA Oligonucleotide Synthesis Market by Country
    • 8.4.2.2 LAMEA Others Market by Country
  • 8.4.3 LAMEA DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
    • 8.4.3.1 LAMEA mRNA Production Market by Country
    • 8.4.3.2 LAMEA Others Market by Country
  • 8.4.4 LAMEA DNases, Ligases, And RNA Polymerases Market by Country
    • 8.4.4.1 Brazil DNases, Ligases, And RNA Polymerases Market
      • 8.4.4.1.1 Brazil DNases, Ligases, And RNA Polymerases Market by DNases Application
      • 8.4.4.1.2 Brazil DNases, Ligases, And RNA Polymerases Market by Ligases Application
      • 8.4.4.1.3 Brazil DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
    • 8.4.4.2 Argentina DNases, Ligases, And RNA Polymerases Market
      • 8.4.4.2.1 Argentina DNases, Ligases, And RNA Polymerases Market by DNases Application
      • 8.4.4.2.2 Argentina DNases, Ligases, And RNA Polymerases Market by Ligases Application
      • 8.4.4.2.3 Argentina DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
    • 8.4.4.3 UAE DNases, Ligases, And RNA Polymerases Market
      • 8.4.4.3.1 UAE DNases, Ligases, And RNA Polymerases Market by DNases Application
      • 8.4.4.3.2 UAE DNases, Ligases, And RNA Polymerases Market by Ligases Application
      • 8.4.4.3.3 UAE DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
    • 8.4.4.4 Saudi Arabia DNases, Ligases, And RNA Polymerases Market
      • 8.4.4.4.1 Saudi Arabia DNases, Ligases, And RNA Polymerases Market by DNases Application
      • 8.4.4.4.2 Saudi Arabia DNases, Ligases, And RNA Polymerases Market by Ligases Application
      • 8.4.4.4.3 Saudi Arabia DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
    • 8.4.4.5 South Africa DNases, Ligases, And RNA Polymerases Market
      • 8.4.4.5.1 South Africa DNases, Ligases, And RNA Polymerases Market by DNases Application
      • 8.4.4.5.2 South Africa DNases, Ligases, And RNA Polymerases Market by Ligases Application
      • 8.4.4.5.3 South Africa DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
    • 8.4.4.6 Nigeria DNases, Ligases, And RNA Polymerases Market
      • 8.4.4.6.1 Nigeria DNases, Ligases, And RNA Polymerases Market by DNases Application
      • 8.4.4.6.2 Nigeria DNases, Ligases, And RNA Polymerases Market by Ligases Application
      • 8.4.4.6.3 Nigeria DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
    • 8.4.4.7 Rest of LAMEA DNases, Ligases, And RNA Polymerases Market
      • 8.4.4.7.1 Rest of LAMEA DNases, Ligases, And RNA Polymerases Market by DNases Application
      • 8.4.4.7.2 Rest of LAMEA DNases, Ligases, And RNA Polymerases Market by Ligases Application
      • 8.4.4.7.3 Rest of LAMEA DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application

Chapter 9. Company Profiles

• 9.1 Thermo Fisher Scientific, Inc.
  • 9.1.1 Company Overview
  • 9.1.2 Financial Analysis
  • 9.1.3 Segmental and Regional Analysis
  • 9.1.4 Research & Development Expenses
  • 9.1.5 Recent strategies and developments:
    • 9.1.5.1 Partnerships, Collaborations, and Agreements:
    • 9.1.5.2 Product Launches and Product Expansions:
    • 9.1.5.3 Acquisition and Mergers:
  • 9.1.6 SWOT Analysis
• 9.2 Merck KGaA
  • 9.2.1 Company Overview
  • 9.2.2 Financial Analysis
  • 9.2.3 Segmental and Regional Analysis
  • 9.2.4 Research & Development Expense
  • 9.2.5 Recent strategies and developments:
    • 9.2.5.1 Partnerships, Collaborations, and Agreements:
    • 9.2.5.2 Acquisition and Mergers:
  • 9.2.6 SWOT Analysis
• 9.3 Agilent Technologies, Inc.
  • 9.3.1 Company Overview
  • 9.3.2 Financial Analysis
  • 9.3.3 Segmental and Regional Analysis
  • 9.3.4 Research & Development Expense
  • 9.3.5 Recent strategies and developments:
    • 9.3.5.1 Acquisition and Mergers:
  • 9.3.6 SWOT Analysis
• 9.4 Promega Corporation
  • 9.4.1 Company Overview
  • 9.4.2 Recent strategies and developments:
    • 9.4.2.1 Product Launches and Product Expansions:
    • 9.4.2.2 Geographical Expansions:
  • 9.4.3 SWOT Analysis
• 9.5 RayBiotech Life, Inc.
  • 9.5.1 Company Overview
  • 9.5.2 SWOT Analysis
• 9.6 Qiagen N.V.
  • 9.6.1 Company Overview
  • 9.6.2 Financial Analysis
  • 9.6.3 Regional Analysis
  • 9.6.4 Research & Development Expenses
  • 9.6.5 Recent strategies and developments:
    • 9.6.5.1 Partnerships, Collaborations, and Agreements:
    • 9.6.5.2 Product Launches and Product Expansions:
  • 9.6.6 SWOT Analysis
• 9.7 Abnova Corporation
  • 9.7.1 Company Overview
  • 9.7.2 Recent strategies and developments:
    • 9.7.2.1 Partnerships, Collaborations, and Agreements:
  • 9.7.3 SWOT Analysis
• 9.8 Takara Bio Inc. (Takara Holdings Inc.)
  • 9.8.1 Company Overview
  • 9.8.2 Financial Analysis
  • 9.8.3 Segmental and Regional Analysis
  • 9.8.4 Research & Development Expenses
• 9.9 BPS Bioscience, Inc.
  • 9.9.1 Company Overview
• 9.10. New England Biolabs, Inc.
  • 9.10.1 Company Overview
  • 9.10.2 SWOT Analysis

Chapter 10. Winning Imperatives of DNases, Ligases, And RNA Polymerases Market